NCT00161018View on ClinicalTrials.gov

New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Schizophrenia
Interventions
DRUG

Quetiapine, Risperidone, Fluphenazine

Trial Locations (1)

21228

Maryland Psychiatric Research Center, Catonsville

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT00161018 - New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia | Biotech Hunter | Biotech Hunter